This section shares educational news and research updates related to sarcoidosis. Evidence can change, so consider the date, source and level of research before drawing conclusions. News items do not provide a diagnosis or a personal treatment plan. Discuss important findings and possible treatment changes with your clinician.

Latest research and professional publications

Here we provide understandable summaries of new research, expert positions and international projects related to sarcoidosis. Each publication highlights what was studied, what the authors concluded, the main limitations of the findings and a link to the source. The information is educational and does not replace a medical examination or a conversation with a doctor.

Original archive (Croatian and English)

SARCOIDOMICS: European network for sarcoidosis research

The ERS research network SARCOIDOMICS brings together European centers to improve understanding of sarcoidosis and the risk factors for a more severe disease course. The project promotes coordinated collection of clinical data, imaging findings, and biological samples, as well as connections between researchers from different countries.

Read more »

Namilumab for pulmonary sarcoidosis: the trial showed no clinical benefit

The phase II RESOLVE-Lung trial evaluated namilumab in people with active pulmonary sarcoidosis. The trial included 107 participants. Namilumab did not provide a clinical benefit compared with placebo; a key outcome related to the need for additional treatment occurred in 37.5% of participants in the namilumab group and 23.5% in the placebo group.

Read more »

WASOG position paper: a more thoughtful use of corticosteroids

WASOG, with support from AASOG, has published a position paper on a more thoughtful use of oral corticosteroids in sarcoidosis. These medicines can quickly reduce inflammation, but long-term use can cause significant side effects. The authors advocate assessing benefits and risks for each patient and considering steroid-sparing strategies when medically appropriate.

Read more »